Cell Therapeutics (CTIC) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cell Therapeutics (CTIC)

An SI Board Since August 1997

Posts	SubjectMarks	Bans	Symbol
946	45	0	CTIC

Emcee: Regis McConnell	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
696	Series of interesting posts on yahoo MB by an individual claiming to be one of t	Extra Pale	-	6/15/2005
695	Tuck, MF seems a little harsh, but an accurate reflection of the market's	Ian@SI	-	6/15/2005
694	MF overviews CTIC's situation, though it makes no mention of Pixantrone: &g	tuck	-	6/15/2005
693	CEPH buys Trisenox.	barkdog	-	6/13/2005
692	CEPH buys Trisenox. marketwatch.com{C0D2D8FF-35AA-4ADC -9371-3C2CED632C1A}&	barkdog	-	6/13/2005
691	I'd expected that we'd see Trisenox sold by the end of May. Guess I was	Ian@SI	-	6/1/2005
690	Thanks, Erik. That would have taken me some digging to figure out. Cheers, Tu	tuck	-	5/25/2005
689	No, on the contrary. Pixantrone is supposed to be the anthracycline(-derivative)	Icebrg	-	5/25/2005
688	From the names of the two drugs it sounds as if the two are chemically related.	tuck	-	5/25/2005
687	<i>U.S. FDA warns of heart risks from Serono drug Wed May 25, 2005 01:35 A	Icebrg	-	5/25/2005
686	Answering my own Q. Stock has traded within an 8 cent range on relatively low	Ian@SI	-	5/19/2005
685	The tone in his voice when he talked about EE as a clinical trial site seemed to	Ian@SI	-	5/19/2005
684	I believe there are a multitude of consequences. Surely, there could be greater	gcrispin	-	5/19/2005
683	It was indeed an interesting exchange. Bianco evidently was not able to grasp th	Icebrg	-	5/19/2005
682	<One doubt raised by a questioner was whether or not all the Eastern Europe p	gcrispin	-	5/19/2005
681	Just listened to CTIC's conference call re ASCO data presented. Most intere	Ian@SI	-	5/18/2005
680	Ground needs to be worked prior to offering, it seems to me. M2	Mao II	-	5/18/2005
679	Seems that CTIC isn't happy with the market's response to its ASCO prese	Ian@SI	-	5/17/2005
678	This is a poor story: "When it was over, some walked out quietly shaking th	Mao II	-	5/16/2005
677	Top cancer researchers unconvinced by Xyotax trials so far By Luke Timmerman S	Icebrg	-	5/16/2005
676	Thank you Erik. I had naively assumed that since vinorelbine was approved as a s	tom pope	-	5/15/2005
675	It may raise some eyebrows, yes. But will be enough for approval? I don't th	Icebrg	-	5/15/2005
674	Still, the results are noteworthy in the light of vinorelbine's status, don&	tom pope	-	5/15/2005
673	Erik, Many thanks for the clear answers. Ian	Ian@SI	-	5/15/2005
672	The patients in the control arm had the choice of using either vinorelbine och g	Icebrg	-	5/15/2005

Go to reply# or date (mm/dd/yy):